An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
Abstract Dengue virus (DENV), from the genus flavivirus of the family flaviviridae, causes serious health problems globally. Human monoclonal antibodies (HuMAb) can be used to elucidate the mechanisms of neutralization and antibody-dependent enhancement (ADE) of DENV infections, leading to the devel...
Guardado en:
Autores principales: | Tomohiro Kotaki, Takeshi Kurosu, Ariadna Grinyo-Escuer, Edgar Davidson, Siti Churrotin, Tamaki Okabayashi, Orapim Puiprom, Kris Cahyo Mulyatno, Teguh Hari Sucipto, Benjamin J. Doranz, Ken-ichiro Ono, Soegeng Soegijanto, Masanori Kameoka |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b08a284eec634976b8ba9f7d74a2d036 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Detection of Knockdown-Resistance Mutations (V1016G and F1534C) in Dengue Vector from Urban Park, Surabaya, Indonesia
por: Shifa Fauziyah, et al.
Publicado: (2021) -
Cross-reactivity of human monoclonal antibodies generated with peripheral blood lymphocytes from dengue patients with Japanese encephalitis virus
por: Pipattanaboon C, et al.
Publicado: (2013) -
Limited cross-reactivity of mouse monoclonal antibodies against Dengue virus capsid protein among four serotypes
por: Noda M, et al.
Publicado: (2012) -
A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation
por: Tomohiro Kotaki, et al.
Publicado: (2021) -
A Novel High-Potency Tetanus Vaccine
por: Amanda Przedpelski, et al.
Publicado: (2020)